Effects of Empagliflozin on Left Ventricular Remodeling in Patients with Type 2 Diabetes and Coronary Artery Disease: Echocardiographic Substudy of the EMPA-HEART CardioLink-6 Randomized Clinical Trial

Karan Bami; Sumeet Gandhi; Howard Leong-Poi; Andrew T Yan; Edwin Ho; Mohammed Zahrani; Vinay Garg; Fei Zuo; Hwee Teoh; Adrian Quan; Lawrence A Leiter; Richard E Gilbert; Bernard Zinman; Kevin E Thorpe; Peter Juni; C David Mazer; Subodh Verma; Geraldine Ong; Kim A Connelly

Journal article

Effects of Empagliflozin on Left Ventricular Remodeling in Patients with Type 2 Diabetes and Coronary Artery Disease: Echocardiographic Substudy of the EMPA-HEART CardioLink-6 Randomized Clinical Trial

Karan Bami, Sumeet Gandhi, Howard Leong-Poi, Andrew T Yan, Edwin Ho, Mohammed Zahrani, Vinay Garg, Fei Zuo, Hwee Teoh, Adrian Quan, Lawrence A Leiter, Richard E Gilbert, Bernard Zinman, Kevin E Thorpe, Peter Juni, C David Mazer, Subodh Verma, Geraldine Ong, Kim A Connelly

Journal of the American Society of Echocardiography | MOSBY-ELSEVIER | Published : 2020

DOI: 10.1016/j.echo.2020.02.005

University of Melbourne Researchers

Richard Gilbert Author Medicine - St Vincent's Hospital

Kim Connelly Author Medicine - St Vincent's Hospital

Grants

Funding Acknowledgements

This trial was supported by an unrestricted investigator-initiated study grant from Boehringer Ingelheim to Drs. Verma and Zinman. The study sponsor was not involved in the study design; data collection, analysis, and interpretation; the writing of this report; or the decision to submit for publication.